Frequent and possibly inappropriate use of combination therapy with an oral anticoagulant and antiplatelet agents in patients with atrial fibrillation in Europe.

Abstract

PURPOSE Combined oral anticoagulant (OAC) and antiplatelet (AP) therapy is generally discouraged in atrial fibrillation (AF) outside of acute coronary syndromes or stenting because of increased bleeding. We evaluated its frequency and possible reasons in a contemporary European AF population. METHODS The PREvention oF thromboembolic events-European… (More)
DOI: 10.1136/heartjnl-2014-305486

Topics

8 Figures and Tables

Cite this paper

@article{Caterina2014FrequentAP, title={Frequent and possibly inappropriate use of combination therapy with an oral anticoagulant and antiplatelet agents in patients with atrial fibrillation in Europe.}, author={Raffaele De Caterina and Bettina Ammentorp and Harald Darius and Jean-Yves le Heuzey and Giulia Renda and Richard John Schilling and Tessa Schliephacke and Paul-Egbert Reimitz and Josef Schmitt and Christine Schober and J{\'o}se Luis Zamorano and Paulus Kirchhof}, journal={Heart}, year={2014}, volume={100 20}, pages={1625-35} }